Behavior and significance of autoantibodies in type 1 autoimmune hepatitis

Journal of Hepatology

Volumn 30, Issue 3, 1999, Pages 394-401

  Czaja, Albert J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Autoantibodies; Autoimmune hepatitis

Indexed keywords

AUTOANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; AUTOIMMUNE HEPATITIS; DISEASE CLASSIFICATION; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0033034609     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80096-8     Document Type: Article

References (26)

1. Czaja AJ, Davis GL, Ludwig J, Baggenstoss AH, Taswell HF. Autoimmune features as determinants of prognosis in steroidtreated chronic active hepatitis of uncertain etiology. Gastroenterology. 85:1983;713-717.
2. Czaja AJ. Natural history, clinical features, and treatment of autoimmune hepatitis. Semin Liver Dis. 4:1984;1-12.
3. Czaja AJ, Manns MP. The validity and importance of subtypes of autoimmune hepatitis: a point of view. Am J Gastroenterol. 90:1995;1206-1211.
4. Czaja AJ. Autoimmune chronic active hepatitis - a specific entity? The negative argument. J Gastroenterol Hepatol. 5:1990;343-351.
5. Czaja AJ. Autoantibodies. Baillieres Clin Gastroenterol. 9:1995;723-744.
6. Johnson PJ, McFarlane IG, Alvarez F, Bianchi FB, Bianchi L, Burroughs A, et al. Meeting Report. International Autoimmune Hepatitis Group. Hepatology. 18:1993;998-1005.
7. Czaja AJ. Diagnosis and therapy of autoimmune liver disease. Med Clin N Am. 80:1996;973-994.
8. Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB. Frequency and significance of antibodics to actin in type 1 autoimmune hepatitis. Hepatology. 24:1996;1068-1073.
9. Czaja AJ, Nishioka M, Morshed SA, Hachiya T. Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis. Gastroenterology. 107:1994;200-207.
10. Czaja AJ, Manns MP, Homburger HA. Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis. Gastroenterology. 103:1992;1290-1295.
11. Summerskill WHJ, Korman MG, Ammon HV, Baggenstoss AH. Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared. Gut. 16:1975;876-883.
12. Czaja AJ, Carpenter HA. Sensitivity, specificity and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology. 105:1993;1824-1832.
13. Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB. Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology. 24:1996;1068-1073.
14. Galbraith RM, Smith M, Mackenzie RM, Tee DE, Doniach D, Williams R. High prevalence of seroimmunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis. N Engl J Med. 290:1974;63-69.
15. Hooper B, Whittingham S, Mathews JD, Mackay IR, Curnow DH. Autoimmunity in a rural community. Clin Exp Immunol. 12:1972;79-87.
16. Tomer Y, Shoenfeld Y. The significance of natural autoantibodies. Immunological Investigations. 17:1988;389-424.
17. Senecal J-L, Ichiki S, Girard D, Raymond Y. Autoantibodies to nuclear lamins and to intermediate filament proteins: natural, pathologic or pathogenic (editorial)? J Rheumatol. 20:1993;211-219.
18. Griffing WL, Moore SB, Luthra HS, McKenna CH, Fathman CG. Associations of antibodies to native DNA with HLA-DRw3: a possible major histocompatibility complex-linked human immune response gene. J Exp Med. 152:1980;319s-325s.
19. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Genetic predispositions for the immunological features of chronic active hepatitis. Hepatology. 18:1993;816-822.
20. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Genetic predispositions for immunological features in chronic liver diseases other than autoimmune hepatitis. J Hepatol. 24:1996;52-59.
21. Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB. Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis. Dig Dis Sci. 42:1997;1688-1696.
22. Tan EM. Antinuclear antibodies: diagnostic markers and clues to the basis of systemic autoimmunity. Pediatr Infect Dis. 7:1988;S3-S9.
23. Tan EM, Chan EKL, Sullivan KF, Rubin RL. Antinuclear antibodies (ANAs): diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity. Clin Immunol Immunopathol. 47:1988;121-141.
24. Tan EM. Antinuclear antibodies. Diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol. 44:1989;93-151.
25. Czaja AJ, Pfeifer KD, Decker RH, Vallari AS. Frequency and significance of antibodies to asialoglycoprotein receptor in type 1 autoimmune hepatitis. Dig Dis Sci. 41:1996;1733-1740.
26. McFarlane IG, Hegarty JE, McSorley CG, McFarlane BM, Williams R. Antibodies to liver-specific protein predict outcome of treatment withdrawal in autoimmune chronic active hepatitis. Lancet. ii:1984;954-956.